Candid Therapeutics
Drug DiscoveryWebsite
Operator of a biotechnology research designed to create novel, easy-to-administer therapies for autoimmune diseases. The company offers advanced T-cell engager antibodies, precisely redirecting T-cell...
Valuation
$657M
Market implied
Share Price
N/A
Total Raised
$445M
Last Round
Early Stage VC (Series B)
Aug 2024
Latest Funding Round
Early Stage VC (Series B)
Aug 20, 2024
$370M
raised
Investors
+21 other investors